Navigate to Other Sector


Healthcare Newsletter – June 2017

Tough Luck for Biosimilars in June as FDA turns down Two Approvals
Continuing Uncertainty surrounding Trumpcare and Healthcare Coverage
Industry Thrust on Next Generation Sciences calls for early thinking of Commercial Models
Blurring Competitive Lines between Pharma and Medical Devices
EMA Cranberry Ruling set the balls rolling for Regulatory Repealing in Self-care Medical Devices Classification

Contact us to know more…

Discussion — No responses

Show Buttons
Hide Buttons